Navigation Links
Thesan Pharmaceuticals udpeger Dr. Bhaskar Chaudhuri til bestyrelsen i august 2014
Date:8/25/2014

SAN DIEGO, 25. august 2014 /PRNewswire/ -- Thesan Pharmaceuticals meddelte i dag, at firmaet udpeger Bhaskar Chaudhuri Ph.D. til bestyrelsen. Dr. Chaudhuri har mere end 25 års erfaring i ledelse inden for lægemidler, medicinsk forskning og udvikling og markedsføring i USA, EU og nye markeder. Han har ledet udviklingen og FDA-godkendelsen af flere NDA'er og ANDA'er. Senest var Dr. Chaudhuri adm. direktør for Valeant Phamaceutikals, før han blev arbejdende partner i Frazier Healthcare. Før Dr. Chaudhuri kom til Valeant var han adm. direktør for Dow Pharmaceuticals i perioden op til dette firmas opkøb af Valeant. Før Dow arbejdede Dr. Chaudhuri hos Bertek Pharmaceuticals (et datterselskab af Mylan Laboratories) som viceadm. direktør for videnskab og som direktør for dermatologiafdelingen hos Mylan Laboratories. Dr. Chaudhuri har et doktorat i fysisk farmakopé. Har er også medlem af bestyrelsen for flere lægemiddelselskaber.

"Vi er glade for at få Bhaskar i bestyrelsen på nuværende tidspunkt", sagde Gordon Foulkes, Thesan's adm. direktør. "Hans fantastiske CV inden for udvikling af dermatologimidler, hans markedsføringsekspertise og lederrolle i salget af flere dermatologiselskaber vil blive en fantastisk hjælp hos Thesan, når vi starter på at bygge et lederteam op for fremtiden".

"Jeg er helt klart beæret over at blive et medlem af Thesan-teamet", tilføjede Dr. Chaudhuri. Den aktuelle portefølje af banebrydende produkter, der ledes af et team af verdensklasse, giver Thesan grundlag for at være et ekstraordinært dermatologiselskab. Jeg ser frem til at bidrage til Thesans vækst og blive en del af en førende dermatologiorganisation".

Samtidig og i forbindelse med den nylige Serie B-finansiering vil Dr. Pe
'/>"/>

SOURCE Thesan Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing
2. Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody
3. RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2014
4. Global Medical Imaging Reagents (Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and Probes, Radiopharmaceuticals and Quantum Dots) Market - Forecast to 2019
5. Oramed Pharmaceuticals Reports Last Patient Out in Phase IIa Trial for ORMD-0801 in Type 1 Diabetes
6. OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial Officer
7. RXi Pharmaceuticals to Ring the NASDAQ Stock Market Closing Bell
8. RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars
9. Galmed Pharmaceuticals Reports First Half 2014 Financial Results
10. SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services
11. Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015   Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... today reported financial results for the second quarter 2015. ... 2015, we remain on track to achieve our commercial ... Executive Officer of the Company. "Since our last quarterly ...
(Date:7/30/2015)... ... ... part of its 2015 growth plan and as a follow up to the recently announced ... Laboratories is pleased to announce that it has begun construction on a new Microbiological Laboratory. ... be strictly dedicated to basic USP 51, USP 61, and USP 62 testing specific to ...
(Date:7/29/2015)... 2015 US-Australian drug discovery company, Novogen Limited ... is committed to progressing its ground-breaking technology platforms to ... to ensure the Company delivers the best value for ... Ross , said the Company currently had an extensive ... discovery programs and academic partnerships and initiatives, and he ...
(Date:7/29/2015)... ... July 29, 2015 , ... G-CON Manufacturing, Inc., the ... their 2nd generation cell therapy POD® design. The 2nd generation portfolio not only ... a new POD® design. , “G-CON first offered our miniPOD CT product ...
Breaking Biology Technology:SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3
... assay effectively identifies melanoma, LA JOLLA, Calif., ... diagnostics for the early detection of,melanoma and other ... Cancer Research on its non-invasive assay that distinguishes ... Genomic Assay for,the Detection of Melanoma in Suspicious ...
... CEDAR KNOLLS, N.J., April 15 Emisphere,Technologies, Inc. ... will host its,Annual Stockholders Meeting on Thursday, May ... Two Whippany Road, Morristown, New Jersey. The,meeting will ... TECHNOLOGIES, INC., Emisphere Technologies, Inc. is a ...
... -ARIUS report new data and program updates on cancer stem cell ... ... April 15 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX:,ARI), a biotechnology company ... it will be presenting new,findings and program updates related to its ...
Cached Biology Technology:DermTech Study on Melanoma Molecular Diagnostic to Be Presented at AACR 2Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008 2ARIUS presents new findings for anti-cancer antibody programs at AACR 2ARIUS presents new findings for anti-cancer antibody programs at AACR 3ARIUS presents new findings for anti-cancer antibody programs at AACR 4ARIUS presents new findings for anti-cancer antibody programs at AACR 5
(Date:7/21/2015)... July 21, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... announces that it has filed provisional patent 62/192218 ... This invention highlights next generation ... an account, but also the user using unique ...
(Date:7/20/2015)... -- Acuity Market Intelligence,s latest research "The Global Biometrics ... Privacy" forecasts that between 2014 and 2020 nearly ... to smart mobile devices by 2.2 billion mobile ... to generate more than $67.9 billion in total ...    "Biometrics is at the center ...
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... provisional patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION ... new convenient and secure method to make payments.  ... payment methods, introduced with its groundbreaking voice-direct payment ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... Baltimore, MD The human genome shares several peculiarities with the ... Our genetic blueprint contains numerous entities known as transposons, or ... to place on the chromosomes within a cell. ... transposon elements and the decaying remains of former transposons that ...
... meeting of the American Fisheries Society will take place in ... conference is "New Frontiers in Fisheries Management and Ecology: Leading ... http://afs2011.org/ All talks will be at the ... Eat but don,t get eaten: after restoration, young salmon better ...
... discovery by the University of Colorado Boulder and the ... "power plants" within cells known as mitochondria has implications ... and conditions due to mitochondrial defects. Led by ... collaboration with the UC-Davis team led by Professor Jodi ...
Cached Biology News:A 'jumping gene's' preferred targets may influence genome evolution 2A 'jumping gene's' preferred targets may influence genome evolution 3USGS research frontiers on fish at the American Fisheries Society Conference 2USGS research frontiers on fish at the American Fisheries Society Conference 3USGS research frontiers on fish at the American Fisheries Society Conference 4USGS research frontiers on fish at the American Fisheries Society Conference 5USGS research frontiers on fish at the American Fisheries Society Conference 6USGS research frontiers on fish at the American Fisheries Society Conference 7New cellular surprise may help scientists better understand human mitochondrial diseases 2
Request Info...
... CultureWell cell culture systems provide ... cultured cells for staining and ... silicone gaskets preassembled with standard ... plates. The entire system is ...
... The Captivate magnetic separator ... be used in conjunction with ... C-21474, C-21476) or other magnetic ... most 96-well microplates. Cell Biology ...
ANTI L-DOPA...
Biology Products: